shalev v, et al. arch intern med 2009; 169:260-268
DESCRIPTION
Shalev V, et al. Arch Intern Med 2009; 169:260-268. Characteristics of Adults Initiating a New Treatment With a Statin Agent, Maccabi Healthcare Services, Israel, 1998-2006 – Part I. Shalev V, et al. Arch Intern Med 2009; 169:260-268. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Shalev V, et al. Arch Intern Med 2009; 169:260-268](https://reader035.vdocuments.net/reader035/viewer/2022062321/56813aab550346895da2a4c7/html5/thumbnails/1.jpg)
Shalev V, et al. Arch Intern Med 2009; 169:260-268
![Page 2: Shalev V, et al. Arch Intern Med 2009; 169:260-268](https://reader035.vdocuments.net/reader035/viewer/2022062321/56813aab550346895da2a4c7/html5/thumbnails/2.jpg)
Characteristics of Adults Initiating a New Treatment With a Statin Agent, Maccabi Healthcare Services, Israel, 1998-2006 – Part I
Shalev V, et al. Arch Intern Med 2009; 169:260-268
![Page 3: Shalev V, et al. Arch Intern Med 2009; 169:260-268](https://reader035.vdocuments.net/reader035/viewer/2022062321/56813aab550346895da2a4c7/html5/thumbnails/3.jpg)
Shalev V, et al. Arch Intern Med 2009; 169:260-268
Characteristics of Adults Initiating a New Treatment With a Statin Agent, Maccabi Healthcare Services, Israel, 1998-2006 – Part II
![Page 4: Shalev V, et al. Arch Intern Med 2009; 169:260-268](https://reader035.vdocuments.net/reader035/viewer/2022062321/56813aab550346895da2a4c7/html5/thumbnails/4.jpg)
Shalev V, et al. Arch Intern Med 2009; 169:260-268
Association Between Potential Determinants and All-Cause Mortality, Maccabi Healthcare Services, Israel, 1998-2006
![Page 5: Shalev V, et al. Arch Intern Med 2009; 169:260-268](https://reader035.vdocuments.net/reader035/viewer/2022062321/56813aab550346895da2a4c7/html5/thumbnails/5.jpg)
Shalev V, et al. Arch Intern Med 2009; 169:260-268
Proportional effects of continuation of statins on reduction in all-cause mortality per 10% proportion of days covered with statins in primary
prevention (A) and secondary prevention (B) cohorts
![Page 6: Shalev V, et al. Arch Intern Med 2009; 169:260-268](https://reader035.vdocuments.net/reader035/viewer/2022062321/56813aab550346895da2a4c7/html5/thumbnails/6.jpg)
Shalev V, et al. Arch Intern Med 2009; 169:260-268
Proportion of Days Covered With Statins and All-Cause Mortality, Maccabi Healthcare Services, Israel, 1998-2006
![Page 7: Shalev V, et al. Arch Intern Med 2009; 169:260-268](https://reader035.vdocuments.net/reader035/viewer/2022062321/56813aab550346895da2a4c7/html5/thumbnails/7.jpg)
Shalev V, et al. Arch Intern Med 2009; 169:260-268
Hazard ratios and 95% confidence
intervals of all-cause mortality according
to proportion of days covered with statins in primary prevention (A) and
secondary prevention (B)
cohorts, Maccabi Healthcare Services,
Israel, 1998-2006